Treatment of Irinotecan Hydrochloride Liposome Injection II in China: a Real World Study of Pancreatic Cancer Patients

This is a real-world observational study in China looking at how well a chemotherapy drug called irinotecan liposome (given as an injection) works in patients with pancreatic cancer outside of a controlled clinical trial setting. **You may be eligible if...** - You have been diagnosed with pancreatic ductal adenocarcinoma (the most common type of pancreatic cancer), confirmed by biopsy or imaging - You are 18 years or older - You are already receiving or planning to receive treatment that includes irinotecan liposome injection - You are willing to participate and have signed consent **You may NOT be eligible if...** - You are pregnant or breastfeeding - Your doctor determines there are other reasons you should not be included Talk to your doctor to see if this trial is right for you.